How to treat diseased implants based on severity of tissue loss

Sept. 27, 2021
Dr. Scott Froum shares his expertise on the treatment of diseased implants and corresponding peri-implant disease at the Perio-Implant Advisory Symposium, October 14–15, in Scottsdale, Ariz. On-demand sessions also available.
Scott Froum, DDS, Editorial Director

Peri-implant disease has been estimated to occur in a range of 10%–40% of placed implants after five years in function. Diagnosis remains a key element in prevention and treatment of this disease. In addition, many treatment modalities have been advocated to treat diseased implants based on tissue loss severity and etiology.

The second annual Perio-Implant Advisory Symposium will address these complex issues, giving attendees knowledge and confidence when faced with these clinical situations. Learn real-world techniques from real-world clinicians.

Register for the symposium and view the conference schedule.

About the Author

Scott Froum, DDS | Editorial Director

Scott Froum, DDS, a graduate of the State University of New York, Stony Brook School of Dental Medicine, is a periodontist in private practice at 1110 2nd Avenue, Suite 305, New York City, New York. He is the editorial director of Perio-Implant Advisory and serves on the editorial advisory board of Dental Economics. Dr. Froum, a diplomate of both the American Academy of Periodontology and the American Academy of Osseointegration, is a volunteer professor in the postgraduate periodontal program at SUNY Stony Brook School of Dental Medicine. He is a PhD candidate in the field of functional and integrative nutrition. Contact him through his website at or (212) 751-8530.